ArticleACS omega2024

Vanillin-Isatin Hybrid-Induced MARK4 Inhibition As a Promising Therapeutic Strategy against Hepatocellular Carcinoma.

Sarfraz Ahmed et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.